Skip to main content

Sanofi

SNYNF
Exchange
OTC
Industry
Pharmaceutical Preparations
SEC CIK
0001121404

No open-market purchases or sales by Sanofi insiders were filed in the last 90 days; 3 institutions reported holding it in 13F filings for Q3 2026, worth $5.58M in total; no superinvestor holds it.

Other share classesSNY

Key figures

Market capADS ratio not in SEC data
–
Insider buysOpen market, last 90 days
0
Insider sellsOpen market, last 90 days
0
13F holdersQ3 2026, +1 vs. previous quarter
3
13F valueReported value at the end of Q3 2026
$5.58M
Superinvestors holdingAt the end of Q3 2026
0

Price chart

From SEC filings, in EUR.

Revenue, FY2025
EUR 43.6B
+6.2% year over year
Net income, FY2025
EUR 7.85B
+39.7% year over year
Free cash flow, FY2025
–
No comparable prior period

Short interest

See short data

From FINRA, settlement date Oct 30, 2026.

Short interest
224.1K
Shares sold short
Change
+113.8K
+103.3% vs. previous
Days to cover
46.57
At average daily volume

Superinvestors holding SNYNF, Q3 2026

Go to the superinvestors tab

No superinvestor reported holding SNYNF at the end of Q3 2026.

Latest insider trades

See all insider trades

Open-market purchases and sales by Sanofi insiders from Form 4, newest first.

No open-market purchases or sales by Sanofi insiders are on file.

Top 10 13F holders, Q3 2026

See all 3 holders

The largest institutional positions in Sanofi at the end of Q3 2026; share changes are against Q2 2026.

Institutions holding SNYNF in Q3 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Cullen Capital Management LLC37,236$3.07M0.03%+37,236New
Generali Investments CEE, investicni spolecnost, a.s.29,339$2.52M0.12%00.0%Unchanged
GAMMA Investing LLC17$1.37K0.00%−41−70.7%Reduced

Holders of 5% or more of SNYNF

See all 1 holders and filings

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Sanofi.

Largest holders of SNYNF from 13D and 13G filings
HolderLatest formStakeChangeFirst filedLatest filingFiling
BlackRock, Inc.13G/A5.80%72.1M shares–Apr 23, 20251 filingApr 23, 2025SEC

7 members of Congress reported 12 trades in Sanofi since 2020. Newest filings:

  1. Alan Armstrong

    Senate · OK · Jul 21, 2026

    Buy$15K-$50K

  2. Lisa C. McClain

    House · MI · Oct 22, 2025

    Sell$1K-$15K

  3. Lisa C. McClain

    House · MI · Sep 12, 2025

    Buy$1K-$15K

  4. Lisa C. McClain

    House · MI · Aug 13, 2025

    Buy$1K-$15K

  5. Lisa C. McClain

    House · MI · Aug 13, 2025

    Sell$1K-$15K